Summit Therapeutics Inc. Income Statement

Income Statement Jan2013 Jan2014 Jan2015 Jan2016 Jan2017 Jan2018 Jan2019 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Revenue & cost
Revenue 3.01M2.87M-0.04M-4.38M3.08M-2.74M57.09M0.74M0.86M1.81M0.70M-15.46M-8.69M
Operating items
Research & Development -7.52M-10.37M-0.02M-0.03M-0.03M52.00M39.81M53.27M85.35M52.00M59.47M150.78M
Selling, General & Administrative -2.77M-3.05M-0.01M-0.01M-0.01M17.01M11.28M19.23M23.61M26.74M30.27M60.53M
Other Operating Expenses 0.000.000.06M0.06M0.01M0.86M14.42M1.00M0.31M
Operating Expenses -10.28M-13.42M-0.02M-0.03M-0.04M74.31M51.09M73.36M108.96M87.21M610.65M226.31M
Operating Income -7.27M-10.53M-20.03M-30.99M-33.28M5.39M-27.47M-53.19M-86.19M-72.09M-609.65M-226.00M
EBIT -7.27M-10.53M-20.03M-30.99M-33.28M7.10M5.39M-27.47M-53.19M-86.19M-72.09M-609.65M-226.00M
Non-operating items
Interest & Investment Income 0.02M-0.01M83.4945.69-0.01M-3.63M3.70M0.01M
Other Non Operating Income 0.01M0.03M0.13M-0.26M0.95M2.55M-0.54M
Non Operating Income 3.69M-1.62M0.28M-2.42M-2.29M11.18M13.37M
Net income details
EBT -7.26M-10.51M-20.76M-0.04M-34.42M6.50M9.08M-29.09M-52.91M-88.60M-78.78M-614.93M-234.68M
Tax Provisions -1.79M0.04M-0.21M
Profit After Tax -7.26M-10.51M-20.76M-0.04M-6.59M6.50M10.87M-29.13M-52.70M-88.60M-78.78M-614.93M-221.31M
Income from Continuing Operations -7.26M-10.51M-20.76M-0.04M-34.42M6.50M10.87M-29.13M-52.70M-88.60M-78.78M-614.93M-234.68M
Consolidated Net Income -7.26M-10.51M-20.76M-0.04M-34.42M6.50M10.87M-29.13M-52.70M-88.60M-78.78M-614.93M-234.68M
Income towards Parent Company -7.26M-10.51M-20.76M-0.04M-34.42M6.50M10.87M-29.13M-52.70M-88.60M-78.78M-614.93M-234.68M
Net Income towards Common Stockholders -7.26M-10.51M-20.76M-0.04M-34.42M6.50M10.87M-29.13M-52.70M-88.60M-78.78M-614.93M-234.68M
Additional items
EPS (Basic) -0.90-1.780.00-2.810.530.63-0.89-0.76-0.67-0.41-0.99-0.31
EPS (Weighted Average and Diluted) 0.63-0.89-0.76-0.67-0.41-0.99-0.31
Shares Outstanding (Weighted Average) 11.67M11.67M11.67M12.26M32.08M32.08M82.26M97.71M201.32M700.84M737.45M
Shares Outstanding (Diluted Average) 22.88M41.92M69.52M131.71M193.34M619.65M718.54M
EBITDA -6.71M-10.53M-0.02M-0.03M-0.03M7.10M10.37M-29.08M-51.73M-87.00M-78.48M-615.48M-221.15M
Interest Expenses -816.904.38M1.15M0.61M-0.62M-0.29M4.40M16.46M8.69M
Tax Rate 0.40%